BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19275689)

  • 1. Adverse reactions to iodinated contrast media administered at the time of endoscopic retrograde cholangiopancreatography (ERCP).
    Pan JJ; Draganov PV
    Inflamm Allergy Drug Targets; 2009 Mar; 8(1):17-20. PubMed ID: 19275689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective evaluation of adverse reactions to iodine-containing contrast media after ERCP.
    Draganov PV; Forsmark CE
    Gastrointest Endosc; 2008 Dec; 68(6):1098-101. PubMed ID: 19028218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Evaluation of Endoscopic Retrograde Cholangiopancreatography-Related Contrast Media Allergic-Like Reaction: A Single Centre Experience.
    Trottier-Tellier F; Harvey L; Baillargeon JD
    Can J Gastroenterol Hepatol; 2018; 2018():6296071. PubMed ID: 29666785
    [No Abstract]   [Full Text] [Related]  

  • 4. [Complications related to the administration of iodinated contrast media].
    Cappeliez O; Lemort M; Dagnelie J
    Rev Med Brux; 1997 Dec; 18(6):373-8. PubMed ID: 9481156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of gadolinium as contrast agent in endoscopic retrograde cholangiopancreatography in patients with iodine allergy].
    Martín Arranz E; Rey Sanz R; Martín Arranz MD; Gea Rodríguez F; Mora Sanz P
    Gastroenterol Hepatol; 2011 Dec; 34(10):672-7. PubMed ID: 22119016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadolinium as an alternative contrast agent for therapeutic ERCP in the iodine-allergic patient.
    Lawrence C; Cotton PB
    Endoscopy; 2009 Jun; 41(6):564-7. PubMed ID: 19533564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iodinated contrast sensitivity in ERCP.
    Draganov P; Cotton PB
    Am J Gastroenterol; 2000 Jun; 95(6):1398-401. PubMed ID: 10894570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of antibiotic prophylaxis in routine endoscopic retrograde cholangiopancreatography investigations as assessed prospectively in a nationwide study cohort.
    Olsson G; Arnelo U; Lundell L; Persson G; Törnqvist B; Enochsson L
    Scand J Gastroenterol; 2015 Jul; 50(7):924-31. PubMed ID: 25769041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid function, thyroid immunoglobulin status, and urinary iodine excretion after enteral contrast-agent administration by endoscopic retrograde cholangiopancreatography.
    Fassbender WJ; Vogel C; Doppl W; Stracke H; Bretzel RG; Klör HU
    Endoscopy; 2001 Mar; 33(3):245-52. PubMed ID: 11293758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adverse contrast medium-induced effects in ERCP].
    Dumoulin FL; Sauerbruch T
    Internist (Berl); 1997 Nov; 38(11):1108. PubMed ID: 9453963
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention of intolerance to iodized contrast media ].
    Soyer P; Levesque M
    Presse Med; 1990 Mar; 19(12):562-5. PubMed ID: 2139217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metrizamide myelography in patients with iodine allergy or previous adverse reactions to iodinated contrast media.
    Tallroth K
    Spine (Phila Pa 1976); 1987; 12(6):574-6. PubMed ID: 3660084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability in management of ERCP-related contrast media reaction.
    Draganov PV; Suarez AL; Cotton PB
    Gastrointest Endosc; 2015 Nov; 82(5):973-4. PubMed ID: 26472008
    [No Abstract]   [Full Text] [Related]  

  • 14. Contrast Reaction Readiness for Your Department or Facility.
    Wang CL; Soloff EV
    Radiol Clin North Am; 2020 Sep; 58(5):841-850. PubMed ID: 32792118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application route of iodinated contrast media as a risk factor for adverse reactions.
    Boehm I
    Gastrointest Endosc; 2009 Sep; 70(3):602; author reply 602. PubMed ID: 19699989
    [No Abstract]   [Full Text] [Related]  

  • 16. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
    Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
    World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic iodine absorption during endoscopic application of radiographic contrast agents for endoscopic retrograde cholangiopancreaticography.
    Mann K; Rendl J; Busley R; Saller B; Seybold S; Hoermann R; Sauerbruch T; Börner W
    Eur J Endocrinol; 1994 May; 130(5):498-501. PubMed ID: 8180679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic duct disruption and duodenal hematoma associated with endoscopic retrograde cholangiopancreatography.
    Sisley JF; Bowden TA; Mansberger AR
    South Med J; 1987 Nov; 80(11):1441-3. PubMed ID: 3686150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of common bile duct stones, failed ERCP and sensitivity to iodine contrast media: what contrast media should we use for an on-table cholangiogram?
    Massey JC; Gokhale JA; Kay CL; Griffith JP
    Ann R Coll Surg Engl; 2008 Oct; 90(7):615. PubMed ID: 18837121
    [No Abstract]   [Full Text] [Related]  

  • 20. Immediate detection of endoscopic retrograde cholangiopancreatography-related periampullary perforation: fluoroscopy or endoscopy?
    Motomura Y; Akahoshi K; Gibo J; Kanayama K; Fukuda S; Hamada S; Otsuka Y; Kubokawa M; Kajiyama K; Nakamura K
    World J Gastroenterol; 2014 Nov; 20(42):15797-804. PubMed ID: 25400465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.